Drug intelligence / Profile preview

butenyl aminolevulinic acid

Development stage
Phase 1
Lead developer
Seoul National University Hospital
Modality
Small Molecules
Administration
Topical
01

Overview

Butenyl aminolevulinic acid (Butenyl ALA) is a lipophilic ester derivative of 5-aminolevulinic acid (ALA) developed by Seoul National University Hospital for the treatment of acne vulgaris. As a prodrug, it is converted intracellularly into protoporphyrin IX (PpIX), a potent photosensitizer. While ALA and its derivatives are typically used in photodynamic therapy (PDT) requiring a specific light source to induce reactive oxygen species and target sebaceous glands, this 1.5% cream formulation is specifically being evaluated for its efficacy and safety without exogenous light irradiation. The butenyl ester modification is designed to enhance skin penetration and lipophilicity compared to standard ALA, potentially allowing for therapeutic effects through ambient light activation or direct biochemical modulation of the pilosebaceous unit.

Other names
Butenyl ALA1.5% Butenyl ALA2-butenyl 5-aminolevulinate

Beyond the preview

Go deeper on butenyl aminolevulinic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on butenyl aminolevulinic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call